Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allarity Therapeutics (ALLR) Other Accumulated Expenses (2024 - 2025)

Allarity Therapeutics' Other Accumulated Expenses history spans 2 years, with the latest figure at $146000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 46.72% year-over-year to $146000.0; the TTM value through Dec 2025 reached $146000.0, down 46.72%, while the annual FY2025 figure was $146000.0, 46.72% down from the prior year.
  • Other Accumulated Expenses reached $146000.0 in Q4 2025 per ALLR's latest filing, down from $604000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $604000.0 in Q3 2025 to a low of $101000.0 in Q2 2024.